All News

AJMC is proud to bring you the first in our series of educational webinars to help our readers and customers better understand some of the trends, challenges and opportunities in the managed care segment

New Hampshire's waiver features premium assistance to shop on the HealthCare.gov exchange and includes a work-referral requirement. CMS resisted linking a waiver to work-related requirements more than a year ago when granting Pennsylvania's waiver.

While sunitinib failed as adjuvant treatment in advanced kidney cancer, this phase 2 study presented at the ongoing annual meeting of The Endocrine Society found that in patients with advanced thyroid cancer, sunitinib treatment resulted in median progression free survival of about 8 months. The authors think their results create sufficient evidence to initiate a phase 3 trial of the drug in thyroid cancer patients.

Kansas health regulators are working to repeal a 2002 law prohibiting the state from regulating mental health drugs used for treating Medicaid patients. Doing so could potentially save the state about $7 million.

New oncology payment models, 340B pricing and disproportionate share hospitals, and the significant difference in reimbursement rates for cancer care services are just some of the challenges faced by community oncology clinics. How do patients make informed decisions on where to go for care?

In an era when most industries easily share big, complicated digital files, healthcare still leans hard on paper printouts and fax machines.

A group of 700 independent Portland doctors, both primary care and specialty, have come together to for a new accountable care organization.

While the wearable market itself has tremendous potential, its effect on the health insurance industry could be just as significant.

Despite the measles outbreak resulting from the anti-vaccination movement in the United States, the percent of Americans who said it's "extremely important" to get children vaccinated continued to fall, according to a new Gallup poll.

A one-minute look at managed care news during the week of March 2, 2015, including oral arguments for King v. Burwell and the approval of the first biosimilar in the United States.

Antelope Valley Hospital in Lancaster, California, shut down its emergency department after the electronic health record and data system failed and the hospital had no backup plan in place.

HHS has released a plan to expand how its agencies make research results freely available to scientists and the public.

The second open enrollment period for the Affordable Care Act went much smoother for consumers signing up for health plans through HealthCare.gov; however, CMS still has much work to do, according to a new report from the Government Accountability Office.

The study, conducted at the Dana-Farber Cancer Institute and published in the Journal of the National Cancer Institute found that the benefits of these personalized cancer products are reported much more frequently than are the limitations.

In a 3-month review of cyber risk management practices in healthcare, the Health Information Trust Alliance (HITRUST) has found that the industry's approach is reactive, inefficient, and labor intensive.

Gilead will be providing Harvoni free of cost to conduct a 600-person trial co-sponsored by the National Institute of Allergy and Infectious Diseases to evaluate if primary care physicians and other healthcare providers, such as nurse practitioners and physician assistants, can use a new antiviral therapy as effectively as specialist physicians.

The study, published in the Journal of Clinical Oncology found that the 5-year survival with ipilimumab (18.2%) was double that with placebo (8.8%) and roughly double the historical survival rate of patients with stage IV melanoma (approximately 10%).

Today the FDA approved the first biosimilar product in the United States. Zarxio (filgrastim-sndz), from Sandoz, Inc, is biosimilar to Amgen Inc's Neupogen (filgrastim), which was first licensed in 1991.

In patients with depression, antidepressants may be more important than statins, according to a study conducted at the Intermountain Medical Center Heart Institute in Salt Lake City, which will be presented at the American College of Cardiology's 64th Annual Scientific Session in San Diego.

A unique coaching project included not only traditional elements like nutrition and exercise but also stress management and sleep.

CMS has proposed several possible changes to the Medicare Shared Savings Program in an effort to attract new participants and to encourage current participants to continue with the program beyond their initial 3-year commitment.

in some of the largest states that did not expand Medicaid, many safety-net hospitals fared pretty well last year-even better than in 2013 in many cases.

Drug-resistant strains of disease (aka "superbugs") have spread in recent years through hospitals, nursing homes, even locker rooms.

Twitter can be used as a real-time measurement of public sentiment for the Affordable Care Act (ACA) and the positivity and negativity of tweets could be used to determine state-level marketplace enrollment, according to researchers.

New proposals from Congress would decrease Medicare payments to hospital outpatient departments, which traditionally serve patients who are more likely to be minority, poorer, and have more severe chronic conditions compared with patients treated in physician offices.

A guideline has been issued that outlines the use of 3-D computed tomography-based radiation therapy planning and volumetric image guidance to more effectively treat pediatric Hodgkin lymphoma and to reduce the radiation dose to normal tissue, thus decreasing the risk of late side effects.

Harold Varmus, MD, who has led the National Cancer Institute at the National Institutes of Health for nearly 5 years, announced today that he will step down from his post, effective March 31, 2015.

A recent audit report out of New York serves as an example of state Medicaid programs that may not be maximizing their collection of revenue from drug rebates for Medicaid managed care enrollees.

AbbVie will spend about $21 billion to buy leukemia drugmaker Pharmacyclics in its first major deal attempt since walking away from a $55 billion takeover of Shire last fall.

The study, which will presented next week at the meeting of the American College of Cardiology, defined how much avoiding diabetes, obesity, and hypertension before age 45 matters if one is later diagnosed with heart failure.